144 related articles for article (PubMed ID: 38275113)
1. SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.
Li S; Li Z; Huang L; Geng Z; Li F; Wu B; Sheng Y; Xu Y; Li B; Xu Y; Gu Z; Qi Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38275113
[TBL] [Abstract][Full Text] [Related]
2. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑671‑5p inhibits cell proliferation, migration and invasion in non‑small cell lung cancer by targeting MFAP3L.
Ye J; Luo W; Luo L; Zhai L; Huang P
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34841435
[TBL] [Abstract][Full Text] [Related]
4. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
[TBL] [Abstract][Full Text] [Related]
5. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
6. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.
Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.
Chen YL; Liu YN; Lin YT; Tsai MF; Wu SG; Chang TH; Hsu CL; Wu HD; Shih JY
J Biomed Sci; 2023 Sep; 30(1):80. PubMed ID: 37726723
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
Liu X; Huang S; Guan Y; Zhang Q
Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.
Wang L; Wu L; Pang J
Oncol Rep; 2020 Oct; 44(4):1550-1560. PubMed ID: 32945481
[TBL] [Abstract][Full Text] [Related]
14. Solute carrier organic anion transporter family member 4A1 promotes colorectal cancer progression and is regulated by miR-1224-5p.
Jiang Y; Zhou X; Li Y; Gao X
Neoplasma; 2022 Jul; 69(4):776-784. PubMed ID: 35331000
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
[TBL] [Abstract][Full Text] [Related]
16. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
[TBL] [Abstract][Full Text] [Related]
18. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
Wei D; Sun L; Feng W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis.
Xia H; Jing H; Li Y; Lv X
Biomed Pharmacother; 2018 Oct; 106():156-162. PubMed ID: 29958139
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
